UMIN ID: UMIN000001036
Registered date:01/04/2008
Cilostazol Reduces Restenosis Following Endovascular Therapy in Patients with Femoro-popliteal Lesions
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Patients who underwent endovascular therapy for symptomatic de novo FP lesions |
| Date of first enrollment | 2004/03/01 |
| Target sample size | 127 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Aspirine 100mg/day, Cilostazol (200mg/day) Aspirine 100mg/day, Ticlopidine (200mg/day) |
Outcome(s)
| Primary Outcome | patency |
|---|---|
| Secondary Outcome | 1) Target lesion revascularization 2) All events included restenosis, amputation and death from any causes |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | acute onset critical limb ischemia, previous bypass surgery or angioplasty for the FP lesions, presence of untreated pelvic lesions, and known intolerance to the medication or contrast agents |
Related Information
| Primary Sponsor | Kansai Rosai Hospital |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | |
| osa-iida@nifty.com | |
| Affiliation | Kansai Rosai Hospital Cardiovascular Division |
| scientific contact | |
| Name | Osamu Iida |
| Address | 3-1-69, Inabaso, Amagasaki city, Hyogo Japan |
| Telephone | 06-6416-1221 |
| Affiliation | Kansai Rosai Hospital Cardiovascular Division |